| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 9 |
| 1 | VALPROIC ACID | 5 |
| 2 | LEVETIRACETAM | 4 |
| 3 | LORAZEPAM | 4 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | ACETAMINOPHEN 500MG | 3 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 7 | CLONAZEPAM | 3 |
| 8 | DARATUMUMAB | 3 |
| 9 | DEXAMETHASONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISATUXIMAB | 3 | 0.0005 |
| 1 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 2 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 3 | ROPINIROLE | 3 | 0.0002 |
| 4 | VALPROIC ACID | 5 | 0.0002 |
| 5 | DEUTETRABENAZINE | 1 | 0.0001 |
| 6 | OLANZAPINE | 9 | 0.0001 |
| 7 | CENOBAMATE | 1 | 0.0001 |
| 8 | VISMODEGIB | 1 | 0.0001 |
| 9 | HUMAN IMMUNOGLOBULIN G | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 10 |
| 1 | Benzodiazepine [EPC] | 8 |
| 2 | Anti-epileptic Agent [EPC] | 6 |
| 3 | Mood Stabilizer [EPC] | 5 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 5 | Corticosteroid [EPC] | 4 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 3 |
| 7 | Nonergot Dopamine Agonist [EPC] | 3 |
| 8 | Opioid Agonist [EPC] | 3 |
| 9 | Thalidomide Analog [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 2 | Nonergot Dopamine Agonist [EPC] | 3 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Anti-epileptic Agent [EPC] | 6 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 5 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 10 | 0.0000 |